case_images: PMC10959545_01
case_images: Changes in the course of drug treatment and clinical indicators of patients. a The patient was treated with medication. b After treatment, the patient showed reduced ACR and PCR results. Albumin level increased and serum creatinine was stable. c The patient's C3 level increased, and SLEDAI, dsDNA values improved. d Changes in white blood cell, lymphocyte, and neutrophil counts were observed during the therapy period. HCQ, hydroxychloroquine; FK, tacrolimus; MMF, mycophenolate mofetil; C3, complement 3; Scr, serum creatinine; ALB, albumin; SLEDAI, systemic lupus erythematosus disease activity index; dsDNA, double-stranded DNA; PCR, protein-to-creatinine ratio; ACR, albumin-to-creatinine ratio; WBC, white blood cell; NEUT, neutrophil; LYMPH, lymphocyte.
case_images: cnd-2024-0014-0001-538033_F01.jpg
case_images: PMC10959545_01_cnd-2024-0014-0001-538033_F01.jpg
case_images: F1
case_images: During follow-up (from ninth to twenty-first month), the patient's renal function and proteinuria were stable, and there were no apparent manifestations of infection (Fig. 1).